INS and Hypoglycemia: While these diabetes medications have a lower risk of hypoglycemia compared to insulin secretagogues when used as add-on therapy after metformin, there is less evidence for their comparative effectiveness and safety when used with insulin.[22] The findings in this study highlight the need for further research into the use of newer diabetes medications in combination with insulin.